Esperion Therapeutics Annual Income Statement (NASDAQ:ESPR)

Add to My Stocks
$48.8 $1.09 (2.28%) ESPR stock closing price Jul 24, 2017 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Esperion Therapeutics stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. Investors typically check YoY or QoQ revenue growth. Along with Esperion Therapeutics assets and Esperion Therapeutics free cash flow, profits as shown in profit and loss statement give key insights about the business. Esperion Therapeutics revenue for 2016 is $/NAN/. View revenue and profit details for latest and last 10 financial years.

show more
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2016 2015 2014 2013 2012 2011
Esperion Therapeutics Net Sales or Revenues
------
Cost Of Goods Sold (COGS)------
Esperion Therapeutics Gross Profit
------
Research & Development Expense57.86M29.8M25.3M16.01M7.99M7.8M
Selling General & Admin Expense18.28M20.23M10.92M6.74M2.2M2.35M
Income Before Depreciation Depletion Amortization-76.15M-50.04M-36.22M-22.75M-10.2M-10.16M
Depreciation Depletion Amortization------
Non Operating Income1.54M0.77M0.11M-2.39M0.03M-0.07M
Interest Expense0.37M0.52M0.27M0.93M1.48M0.57M
Esperion Therapeutics Pretax Income
-74.97M-49.78M-36.37M-26.08M-11.65M-10.81M
Provision for Income Taxes------
Minority Interest------
Investment Gains Losses------
Other Income------
Income Before Extraordinaries & Disc Operations-74.97M-49.78M-36.37M-26.08M-11.65M-10.81M
Extraordinary Items & Discontinued Operations------
Esperion Therapeutics Net Income (Profit/Loss)
-74.97M-49.78M-36.37M-26.08M-11.65M-10.81M
Average Shares used to compute Diluted EPS22.55M22.02M16.37M7.89M3.76M-
Average Shares used to compute Basic EPS22.55M22.02M16.37M7.89M3.76M-
Income Before Nonrecurring Items-74.98M-49.78M-36.38M-23.42M-11.74M-
Income from Nonrecurring Items----2.59M--
Esperion Therapeutics Earnings Per Share Basic Net
-3.33-2.26-2.22-3.31-3.13-
Esperion Therapeutics Earnings Per Share Diluted Net
-3.33-2.26-2.22-3.31-3.13-
EPS Diluted Before Nonrecurring Items-3.33-2.26-2.22-2.98-3.13-
Preferred Dividends Acc Pd------
Dividends Common------
Dividend Per Share Common------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Income statement for another ticker

Before investing one should read a report on Esperion Therapeutics stock analysis. Our Esperion Therapeutics revenue chart gives a clear visual representation of how the topline growth has been. Investors often invest in only those companies where the revenue is growing at a steady rate.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. ESPR stock had a healthy bottom line growth.
  • The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Esperion Therapeutics historical stock prices to check how the price has moved with time. .